Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

129 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Combination of targeted therapy and immunotherapy in melanoma.
Blank CU, Hooijkaas AI, Haanen JB, Schumacher TN. Blank CU, et al. Cancer Immunol Immunother. 2011 Oct;60(10):1359-71. doi: 10.1007/s00262-011-1079-2. Epub 2011 Aug 17. Cancer Immunol Immunother. 2011. PMID: 21847631 Review.
Targeting BRAFV600E in an inducible murine model of melanoma.
Hooijkaas AI, Gadiot J, van der Valk M, Mooi WJ, Blank CU. Hooijkaas AI, et al. Among authors: blank cu. Am J Pathol. 2012 Sep;181(3):785-94. doi: 10.1016/j.ajpath.2012.06.002. Epub 2012 Jul 11. Am J Pathol. 2012. PMID: 22796458
Neurological immune-related adverse events of ipilimumab.
Bot I, Blank CU, Boogerd W, Brandsma D. Bot I, et al. Among authors: blank cu. Pract Neurol. 2013 Aug;13(4):278-80. doi: 10.1136/practneurol-2012-000447. Epub 2013 Mar 13. Pract Neurol. 2013. PMID: 23487828
129 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page